Medical/Pharmaceuticals

SEKISUI Completes £15.7 Million Expansion in cGMP Biopharma CDMO Capacity

Growth of UK facility will enable clinical-grade manufacturing of drug substances for range of biopharmaceutical products BURLINGTON, Mass., Nov. 15, 2024 /PRNewswire/ -- SEKISUI Diagnostics' microbial CDMO business announces it has completed construction of its £15.7 million ($20.7 million) cGM...

2024-11-14 23:45 834

Mabwell's Novel Nectin-4 Targeting ADC 9MW2821 Approved for 2 Clinical Trials by CDE of NMPA

SHANGHAI, Nov. 14, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its novel Nectin-4 targeting ADC (R&D code: 9MW2821) has received IND approval for two clinical studies. The first will explore its use in combination wi...

2024-11-14 22:00 1218

I-Mab Reports Third Quarter 2024 Results

* Givastomig data presented at ESMO 2024 and SITC 2024 highlights encouraging monotherapy data * On track to dose first patient in randomized Phase 2 study of uliledlimab in first-line mNSCLC in 1H 2025 * Appointed Dr. Sean Fu as permanent CEO effective November 1, 2024 * Estimated cash ru...

2024-11-14 20:00 928

Transforming Healthcare with Real-Time AI Image Analytic

Join us to discover how NVIDIA IGX and SDVoE enable seamless ultra-low latency solutions TAIPEI, Nov. 14, 2024 /PRNewswire/ -- Advantech announces enhanced AI detection for endoscopy surgical systems with the integration of its MIC-735M-IO, powered by NVIDIA IGX™, and the VEGA series ultra-low-l...

2024-11-14 18:37 1113

Lilly expands R&D footprint in Singapore with SGD$42 million investment in new Digital Health Innovation Hub

Lilly to drive next-generation AI-powered digital health technology research in Singapore SINGAPORE, Nov. 14, 2024 /PRNewswire/ -- Lilly Digital Health and Lilly Centre for Clinical Pharmacology (LCCP), a wholly owned subsidiary of U.S.-based Eli Lilly and Company (Lilly), today announced the e...

2024-11-14 15:10 1383

Sun Life Survey Reveals Hidden Financial and Mental Health Impacts of Type 2 Diabetes

* One third (33%) of those living with diabetes report a 'severe' or 'significant' financial impact on their lives, with 82% unable to consistently afford the right care.  * 67% of non-diabetics are either 'very concerned' or 'concerned' about the financial burden that would result from a typ...

2024-11-14 14:06 927

Suvoda Awarded US Patent for its eCOA Software Architecture

Low-code, no-code approach accelerates eCOA questionnaire design and deployment, taking questionnaire creation, licensing, and localization off the critical path  PHILADELPHIA, Nov. 14, 2024 /PRNewswire/ -- Suvoda, a global clinical trial technology company specializing in complex studies in the...

2024-11-14 09:00 1221

Join the GenScript Biotech Global Forum in London to Navigate the Future of Cell and Gene Therapies.

PISCATAWAY, N.J., Nov. 13, 2024 /PRNewswire/ -- The global cell and gene therapy (CGT) industry is poised for remarkable growth, driven by significant advances in life sciences and robust investments from capital markets. To strengthen this vital sector, GenScript is bringing together leading sc...

2024-11-13 23:51 984

Datasea Reports First Quarter 2025 Revenue of $21 Million, Up 206% Year-over-Year

Datasea's Top-Line Performance Driven by its Further Penetration of China's 5G AI Applications Segment BEIJING, Nov. 13, 2024 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), aNevada-based technology firm, today released its financial results for its first fiscal quarter...

2024-11-13 22:30 1763

Lunit Partners with VIDI Group to Deliver AI-Powered Mammography to France's Largest Radiology Network

Agreement to make Lunit INSIGHT MMG accessible to over 400 sites across France SEOUL, South Korea, Nov. 13, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced a strategic alliance with VIDI Group, the lar...

2024-11-13 22:00 1496

New Evidence-Based Information from NCCN Offers Tangible and Moral Support for People Trying to Quit Smoking

New NCCN Guidelines for Patients: Quitting Smoking showcases attainable and uplifting options that empower people with cancer to achieve better health outcomes. PLYMOUTH MEETING, Pa., Nov. 13, 2024 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer ...

2024-11-13 21:06 1402

Concord Medical Schedules 2024 Annual Meeting of Shareholders

BEIJING, Nov. 13, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention inChina, today announced that it will hold its 2024 annual general meeting o...

2024-11-13 21:00 1449

Continuity Biosciences Launches to Enable Breakthrough Therapies with Innovative Delivery Technologies

BRADENTON, Fla. and HOUSTON, Nov. 13, 2024 /PRNewswire/ -- Continuity Biosciences, LLC, a new bioscience company dedicated to developing and commercializing cutting-edge technologies for cell reprogramming, immune modulation, and drug delivery, is excited to announce its official launch. The com...

2024-11-13 20:30 1183

NaoTrac Robot Pioneers Robotic Neurosurgery in Bolivia with Successful Brain Tumor Biopsies

HSINCHU, Nov. 13, 2024 /PRNewswire/ -- On November 5, 2024, Bolivia marked a historic moment in neurosurgery at Hospital Arcoiris, where two successful brain tumor biopsy surgeries were conducted using NaoTrac, the world's first autonomous surgical navigation robot. These groundbreaking surgeries...

2024-11-13 20:10 1609

Telix and Eckert & Ziegler to Partner on Actinium-225 Production Technology

MELBOURNE, Australia and BERLIN, Germany, Nov. 13, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into a technology collaboration and licence agreement withBerlin -based Eckert & Ziegler SE (EZAG) for the use of EZAG's cyclotro...

2024-11-13 16:18 1467

Clarivate Healthcare Business Insights Unveils 2023 Revenue Cycle Award Winners

Recognizing Roper St. Francis Healthcare, Bon Secours Mercy Health, and Bronson Methodist Hospital for excellence in Physician and Hospital Groups LONDON, Nov. 13, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, announced the 2023 winners o...

2024-11-13 16:00 1090

Musim Mas Achieves a Top 5 Rank in the Global Child Forum Benchmark 2024

SINGAPORE, Nov. 13, 2024 /PRNewswire/ -- Musim Mas Group reached a significant milestone in the State of Children's Rights and Business 2024 Global Benchmark by Global Child Forum, achieving anoverall score of 9.3 out of 10, placing the Group in the top five of companies globally

2024-11-13 14:38 1347

Caliway Announced EMA Orphan Drug Designation Granted to CBL-514 for Dercum's Disease Treatment

- CBL-514 is the first and only drug to receive EMA Orphan Drug Designation for Dercum's disease treatment. - CBL-514 received both FDA Orphan Drug Designation and Fast Track designation for Dercum's disease treatment earlier this year. - CBL-514 Phase 2 study for Dercum's disease showed that it c...

2024-11-13 13:36 1118

SpaceGut Debuts AI-Driven Gut Health Testing in Malaysia, Offering Personalized Wellness Solutions

KUALA LUMPUR, Malaysia, Nov. 13, 2024 /PRNewswire/ -- SpaceGut,  part of SOL Partnership Sdn Bhd, is proud to introduce Malaysia's first AI-powered at-home Gut Microbiome Test Kit. Officially launched on12 November 2024 at Cookhouse's Artisan's Playground, the innovative k...

2024-11-13 09:00 1834

Health Enthusiasts and Experts Unite at the USANA Health Symposium

MANILA, Philippines, Nov. 13, 2024 /PRNewswire/ -- USANA Philippines, in its unwavering commitment to promote health and wellness, recently conducted its second health symposium held at the SMX Convention Center in Pasay City, bringing together a distinguished lineup of experts in health, wellnes...

2024-11-13 08:57 1487
1234567 ... 610